![]() |
Reldesemtiv Slows Decline in Muscle Control Needed for Speech, Phase 2 Trial Analysis
Reldesemtiv May Reduce Functional Decline in Fast Progressing ALS, New Analysis Suggests
In Fast Advancing ALS, Reldesemtiv May Lower Functional Decline, Data Says Reldesemtiv Slows Decline in Muscle Control Needed for Speech, Phase 2 Trial Analysis Finds Reldesemtiv in ALS Patients Slows Decline in Speech Muscle Control, Trial Data Show FORTITUDE-ALS study results suggest reldesemtiv may have efficaciousness in amyotrophic lateral sclerosis |
All times are GMT -5. The time now is 09:10 AM. |
Powered by vBulletin Copyright ©2000 - 2025, Jelsoft Enterprises Ltd.
vBulletin Optimisation provided by
vB Optimise (Lite) -
vBulletin Mods & Addons Copyright © 2025 DragonByte Technologies Ltd.